Pharmerging Market Set to Hit USD 7.1 Billion by 2034, Driven by Surge in Demand for Cost-Effective Innovative Drugs and Comprehensive Insurance Policies | Report by TMR [Yahoo! Finance]
![Yahoo! Finance](../../../Content/images/providers/Yahoo! Finance.png)
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
July 26, 2024 /PRNewswire/ -- The pharmerging market accounted for US$ 2.1 billion in 2023 . It is expected to advance at a CAGR of 11.6% from 2024 to 2034 and reach US$ 7.1 billion by the end of 2034. Pharmaceuticals are in higher demand to manage and treat chronic diseases, including diabetes, cardiovascular disease, and cancer, as they become more prevalent in emerging economies. The pharmerging market, comprises of nations such as Brazil Russia India , and China (BRIC) and other rapidly emerging economies, these have dynamic environment with multiple opportunities and challenges. These countries account for 40% of the world's population, with a growing middle class and an increasing prevalence of chronic diseases, driving demand for pharmaceuticals. The rapid growth in healthcare expenditures in these markets contrasts sharply with the relatively sluggish growth in G7 countries, showing the shift in global healthcare spending toward pharmerging economies. The pharmaceutical se
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Abbott's Lingo CGM System Gains U.S. Availability: Stock to Gain? [Yahoo! Finance]Yahoo! Finance
- FDA hits Abbott FreeStyle Libre 3 recall with Class I tag [Yahoo! Finance]Yahoo! Finance
- Abbott Laboratories Recalls Some Sensors For Its Popular FreeStyle Libre 3 Glucose Monitoring System [Yahoo! Finance]Yahoo! Finance
- Abbott launches its first over-the-counter continuous glucose monitor in the U.S. [CNBC]CNBC
- Abbott's Lingo™ Continuous Glucose Monitor for Health and Wellness Now Available in the U.S.PR Newswire
ABT
Earnings
- 7/18/24 - Beat
ABT
Sec Filings
- 9/4/24 - Form 4
- 9/4/24 - Form 4
- 9/4/24 - Form 144
- ABT's page on the SEC website